Back to Research Hub
United Therapeutics Corporation
UTHR
$553.14+8.45 (+1.55%)
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
StreetsValue research for United Therapeutics Corporation (UTHR)
Members get the full report for United Therapeutics Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.